Theratechnologies (TSE:TH) Announces Quarterly Earnings Results

Theratechnologies (TSE:TH) announced its quarterly earnings results on Thursday. The company reported C$0.09 EPS for the quarter, reports. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. The business had revenue of C$30.96 million during the quarter.

Theratechnologies Price Performance

TH opened at C$1.74 on Friday. Theratechnologies has a 1 year low of C$1.27 and a 1 year high of C$3.43. The company has a debt-to-equity ratio of 562.07, a current ratio of 1.10 and a quick ratio of 0.64. The company has a market capitalization of C$80.01 million, a price-to-earnings ratio of -9.67, a P/E/G ratio of -8.50 and a beta of 1.73. The firm’s fifty day moving average price is C$1.74 and its two-hundred day moving average price is C$1.83.

About Theratechnologies

Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.